Claris

Claris Lifesciences has received USFDA approval for generic Flumazenil injection used for reversal of the sedative effects of benzodiazepines in the United States. The company […]

Claris Lifesciences has received USFDA approval for generic anaesthetic Bupivacaine injection. The new drug Bupivacaine hydrochloride will be sold in 8.25 per cent dextrose injection […]

Claris Lifesciences has received USFDA approval for generic Tobramycin injection used for the treatment of bacterial infections. The estimated market size of the product in […]